GDF11, a new member of the TGF-␤ gene superfamily, regulates anterior/posterior patterning in the axial skeleton during mouse embryogenesis. Gdf11 null mice display skeletal abnormalities that appear to represent anterior homeotic transformations of vertebrae consistent with high levels of Gdf11 expression in the primitive streak, presomitic mesoderm, and tail bud. However, despite strong Gdf11 expression in the limb throughout development, this structure does not appear to be affected in the knockout mice. In order to understand this dichotomy of Gdf11 expression versus Gdf11 function, we identified the chicken Gdf11 gene and studied its role during limb formation. In the early limb bud, Gdf11 transcripts are detected in the subectodermal mesoderm at the distal tip, in a region overlapping the progress zone. At these stages, Gdf11 is excluded from the central core mesenchyme where precartilaginous condensations will form. Later in development, Gdf11 continues to be expressed in the distal most mesenchyme and can also be detected more proximally, in between the forming skeletal elements. When beads incubated in GDF11 protein were implanted into the early wing bud, GDF11 caused severe truncations of the limb that affected both the cartilage elements and the muscle. Limb shortening appeared to be the result of an inhibition of chondrogenesis and myogenesis and using an in vitro micromass assay, we confirmed the negative effects of GDF11 on both myogenic and chondrogenic cell differentiation. Analysis of molecular markers of skeletal patterning revealed that GDF11 induced ectopic expression of Hoxd-11 and Hoxd-13, but not of Hoxa-11, Hoxa-13, or the Msx genes. These data suggest that GDF11 may be involved in controlling the late distal expression of the Hoxd genes during limb development and that misregulation of these Hox genes by excess GDF11 may cause some of the observed alterations in skeletal element shape. In addition, GDF11 induced the expression of its own antagonist follistatin, indicating that the activity of GFD11 may be limited by a negative feedback mechanism. The data from our studies in the chick suggest that Gdf11 plays a role in the formation and development of the avian limb skeleton.
INTRODUCTION
Bone morphogenetic proteins (BMPs) and the closely related growth and differentiation factors (GDFs) are members of the TGF-␤ superfamily of peptide growth factors that function as regulators of cell proliferation, programmed cell death, terminal differentiation, and specification of developmental fate (Hogan, 1996) . BMPs were originally isolated by their ability to form ectopic cartilage and bone in adult animals and have proven to be key molecules for bone growth and repair in the adult skeleton (Wozney et al., 1988; Gamer and Rosen, 2000) . BMPs exert their biological effects by signaling through type I and type II serine-threonine kinase receptors to the nucleus via the Smad gene family (Whitman, 1998) . The activity of BMPs can be modulated by a growing list of antagonist proteins, including noggin, chordin, follistatin, and gremlin, that bind to a BMP, preventing it from interacting with its receptor (Thomsen, 1997) .
GDF11 is a recently identified member of the TGF-␤ family that is most closely related to GDF8 (myostatin), a negative regulator of muscle growth (McPherron et al., 1997) . In the mouse embryo, Gdf11 is first detected in regions where new mesodermal cells arise, such as the primitive streak and tail bud (Gamer et al., 1999; Nakashima et al., 1999; McPherron et al., 1999) . As development proceeds, Gdf11 shows strong expression in the branchial arches, limb buds, and dorsal neural tube (Gamer et al., 1999; Nakashima et al., 1999; McPherron et al., 1999) . In late stage embryos, Gdf11 is also found in terminally differentiated odontoblasts, the nasal epithelium, the retina, and the brain (Nakashima et al., 1999) . Mice homozygous for a targeted deletion of Gdf11 exhibited extensive axial skeletal patterning defects as well as renal and palate abnormalities. The Gdf11 knockout mice have an elongated trunk and a reduced or absent tail which appears to be the result of the formation of additional thoracic and lumbar vertebrae . The mutant phenotype is thought to be due to a broad homeotic transformation of vertebrae to more anterior developmental fates . This also results in alterations in the expression pattern of several Hox genes in the mutant mice, suggesting that Gdf11 acts upstream of these transcription factors during axial patterning . Thus, GDF11 is thought to be one of the first secreted molecules directly involved in the global specification of positional identity along the anterior-posterior body axis.
It is clear from functional studies in the mouse that
Gdf11 plays an important role in the proper formation of the axial skeleton. Using Xenopus embryos, we showed that GDF11 was a potent mesoderm inducer that could be specifically inhibited by the activin/BMP antagonist, follistatin (Gamer et al., 1999) . Since both Gdf11 and follistatin are expressed in the limb during skeletogenesis, we were interested in determining why this structure was unaffected in the Gdf11 knockout mice. To begin to understand the role of Gdf11 in the appendicular skeleton, we analyzed its expression pattern and function in the developing chick limb. Gdf11 is highly expressed in distal mesenchyme of the limb bud, but excluded from the central core prechondrogenic mesenchyme. Implantation of beads soaked in GDF11 protein into early wing buds caused a dramatic shortening of the limbs. The truncation appeared to be due to inhibition of both chondrogenesis and myogenesis, as well as to an increase in apoptosis in the affected limbs. The phenotype of the GDF11 wings was similar to what has Wing bud (F) and leg bud (G) show strong Gdf11 expression in the distal mesenchyme of the developing autopod. Gdf11 transcripts can be detected in proximal stripes adjacent to the developing cartilages (arrowheads). (H and I) Expression of Gdf11 in stage 26/27 limbs. In the wing bud (H) and leg bud (I), Gdf11 localizes to the distal mesenchyme surrounding the digits and the mesenchyme around the developing skeletal elements (arrowheads).
been previously reported for the misexpression of Hoxd-11 and Hoxd-13 in the early chick limb (Goff and Tabin, 1997) . We found that GDF11 induced the ectopic expression of both of these genes. These data suggest that Gdf11 may regulate the late distal expression of Hox genes during the growth and differentiation of the limb skeleton. Interestingly, GDF11 also caused the ectopic expression of follistatin, indicating that its activity may be controlled by a negative feedback mechanism with its own antagonist. From studies in the chick, we conclude that Gdf11 may play an important role in the formation and patterning of the limb in the avian embryo.
MATERIALS AND METHODS

Cloning Chick GDF-11
The chick Gdf11 gene was isolated by screening a 5-day chicken embryo cDNA library (Stratagene) with a probe derived from the propeptide region of mouse Gdf11 using standard conditions.
FIG. 2.
Skeletal alterations induced by implantation of GDF11 beads in the early wing bud. Beads incubated in GDF11 protein were implanted into the forelimb bud at stage 20 -22. For skeletal analysis, contralateral control and GDF11-treated wings were isolated from day 5 (A), day 7 (B and C), and day 8 (D and E) embryos, stained with Alcian blue, and cleared with KOH-glycerol. (A) Implantation of GDF11 beads causes a significant decrease in the size of the limb bud compared to the contralateral control at day 5 (24 h) after treatment. The control wing is on top and the GDF11-treated wing is on the bottom. (B) Normal skeletal pattern of a control wing at day 7. (C) Skeletal pattern of a day 7 GDF11-treated wing implanted at stage 20. The humerus is shortened and widened while the radius, ulna, and digits all appear normal. (D) Normal skeletal pattern of a control wing at day 8. (E) Skeletal pattern of a day 8 GDF11-treated wing implanted at stage 21. The humerus, radius, and ulna are all reduced in length and wider. Note the fusion of the radius and ulna at their proximal ends. The arrowheads in A, C, and E show the location of the bead. h, humerus; r, radius; u, ulna.
Hybridizations were carried out overnight at 45°C using QuikHyb solution (Stratagene) and membranes were washed at a final stringency of 1ϫ SSC, 0.1% SDS at 55°C. A partial cDNA clone was isolated whose identity as chicken Gdf11 was confirmed by DNA sequence analysis comparing chick DNA sequences with the reported sequences for human and mouse Gdf11 (Gamer et al., 1999) . A region corresponding to the propeptide of chick Gdf11 was subcloned into pBluescript (Stratagene). An antisense riboprobe was generated by digesting the construct with EcoRI and transcribing with T7 polymerase.
Embryos
Embryos were obtained by incubating fertilized White Leghorn chicken eggs (SPAFAS) at 39°C and staged according to Hamburger and Hamilton (1951) .
In Situ Hybridizations
Embryos were fixed in 4% paraformaldehyde in PBS overnight at 4°C and processed for whole-mount in situ hybridization as described in Riddle et al. (1993) . Whole-mount embryos were processed, embedded in paraffin, and sectioned as in Nieto et al. (1996) . Plasmids containing probes for Msx1, Msx2, MyoD , and Pax3 were kindly provided by Cliff Tabin. The probe for chicken follistatin was obtained by RT-PCR using primers and conditions as described in Merino et al. (1999a) .
Experimental Manipulation of the Limbs
Eggs were windowed at the appropriate stage and the limb buds were exposed. Affi-Gel blue beads (Bio-Rad) of a diameter ranging from 100 to 150 m were washed in PBS and incubated for 1 h at room temperature in human recombinant GDF11 at a concentration of 0.5 mg/ml. Beads were implanted in the distal mesenchyme subadjacent to the apical ectodermal ridge (AER) of stage 20 wing buds through incisions made by tungsten dissection needles. After the operation, eggs were returned to the incubator for the desired length of time.
Morphological Analysis of Limbs
The skeletal morphology of the limbs was studied in wholemount specimens after cartilage staining with Alcian blue. Beadimplanted embryos that had developed to the appropriate stage were fixed in 4% paraformaldehyde in PBS overnight at 4°C. Embryos were rinsed several times in PBS and stained for 5 h with Alcian blue solution (0.02% Alcian blue 8GX dissolved in a mixture of 70% ethanol and 30% glacial acetic acid). After staining was complete, embryos were washed in 70% ethanol and distilled water for 1 h each before processing through a 0.5% potassium hydroxide:glycerol series (3:1, 1:1, 1:3) for 2 h at each step and finally stored in 100% glycerol.
For histology, stained whole skeletal preparations of control and GDF11-treated wings were processed back through the potassium hydroxide:glycerol series (1:3, 1:1, 3:1) and then rinsed in H 2 O. The wings were then embedded in JB4 resin (PolyScience) and 5-m sections were collected and analyzed by light microscopy.
Analysis of Apoptosis and Cell Proliferation
The distribution of cell death was analyzed at 24 h by TdTmediated dUTP nick end labeling (TUNEL). Immunohistochemical detection of cells undergoing apoptosis was performed on paraffinsectioned GDF11 bead-implanted and control bead-implanted limb buds using the in situ cell death detection kit (Boehringer Mannheim) according to the manufacturer's directions.
To assess changes in cell proliferation, bromodeoxyuridine (BrdU) incorporation analyses were performed exactly as described in Zou et al. (1997) .
Micromass Cultures
High-density microtiter micromass cultures were carried out as described in Daniels et al. (1996) , using stage 23/24 forelimb buds.
Recombinant human GDF11 was initially tested at concentrations ranging from 100 to 1000 ng/ml and a dose of 250 ng/ml was chosen for experiments as it gave the most consistent results. Recombinant human BMP-2 was also used at a concentration of 250 ng/ml. Media and growth factors were changed every day. The cultures were stained with Alcian blue (pH 1.0) to visualize chondrogenic nodule formation (Lev and Spicer, 1964) . To detect myogenic cells, cultures were stained with MF-20, a monoclonal antibody specific for sarcomeric myosin (Developmental Studies Hybridoma Bank) using an anti-mouse IgG Vectastain Elite ABC kit (Vector Laboratories).
RESULTS
Cloning and Embryonic Limb Expression of Chicken Gdf11
To further understand the role of Gdf11 in vertebrate development, we screened a day 5 chicken embryo cDNA library and isolated a novel cDNA that upon sequencing was shown to encode chicken Gdf11. In the carboxyterminal mature region, chicken GDF11 protein has 99% identity to mouse and human GDF11 (data not shown).
The expression of Gdf11 during chick limb bud development was determined by whole-mount in situ hybridization. Gdf11 is initially expressed at stage 19 in the distal mesoderm at the tip of the limb bud (Fig. 1A) . At stages 20 -22, Gdf11 transcripts localize to subectodermal mesenchyme where they are expressed in a gradient, with highest levels more anterior and little or no expression in the proximal-posterior mesoderm of the bud (Figs. 1B-1E). At these and later stages, Gdf11 is not detected in the AER or the central core prechondrogenic mesenchyme . From stages 24 -27, Gdf11 continues to be strongly expressed in the distal most mesoderm of the developing autopod (Figs. 1F-1I). At stage 25, Gdf11 transcripts can be detected more proximally in stripes of mesenchyme that flank the condensing cartilages (see arrowheads in Figs. 1G-1I). We found similar expression patterns of Gdf11 in both the developing wing and leg. Our results reveal that Gdf11 has a dynamic localization pattern during limb formation, being highly expressed in the distal progress zone mesenchyme and excluded from the prechondrogenic mesenchyme that will eventually form the skeletal elements.
Gdf11 Causes Truncations of Skeletal Elements in the Limb
The potential role of Gdf11 during early limb development was investigated by implanting beads incubated in GDF11 protein into the distal mesoderm of stage 20 -22 chick wing buds (n ϭ 110). This treatment resulted in localized reductions of skeletal structures within the limb. The phenotype was clearly detectable after 24 h as a decrease in the size of the limb bud along all three axes ( Fig.  2A) . When embryos were allowed to develop further (from 7 to 11 days), skeletal preparations of the treated wings revealed a dramatic shortening and widening of the limb elements in both the stylopod and the zeugopod (Figs. 2C and 2E). The length of the cartilage in the autopod was almost always normal. The particular proximal-distal skeletal element affected depended on the stage at which the limb was treated. If the bead was placed in the wing bud at stage 20, the humerus was most frequently truncated (compare Fig. 2C to Fig. 2B ). When the bead was implanted at stage 21-22 and its final location was the joint region, the humerus, radius, and ulna were all shortened (compare Fig.  2E to Fig. 2D ). Figure 2E demonstrates the additional cartilage phenotype we often observed in these limbs, a fusion of the radius and ulna at their proximal end. The affected skeletal elements in the GDF11-treated wings were anywhere from 50 to 85% the length of the contralateral controls. Although the size of the skeletal elements was altered, their patterning appeared normal and all the cartilage elements were present within the GDF11 wings. Almost all of the GDF11-treated embryos displayed some recognizable limb alteration and these effects were never seen in control limbs implanted with beads soaked in PBS.
The observed truncation of the skeletal elements in the GDF11-treated limbs could result from changes in cell proliferation, cell death, or cell differentiation. To investigate the first possibility, BrdU-incorporation analysis was performed on limbs 24 and 48 h after implantation with GDF11 beads. No differences in the labeling of proliferating cells either around the bead or in other regions of the limb were detected between control and GDF11-treated wings (n ϭ 5) (data not shown).
Increases in programmed cell death in the early limb bud could also play a role in the observed truncations of skeletal elements, due to a reduction in the number of mesenchymal cells needed to form the limb. Since BMPs have been shown to be potent apoptotic signals for the undifferentiated limb mesenchyme (Zou and Niswander, 1996; Ganan et al., 1996) , we performed TUNEL assays on GDF11 bead-implanted limbs. We found a high localized concentration of TUNEL-positive cells surrounding the GDF11 bead after 24 h (n ϭ 5) compared to contralateral control wing buds (Figs. 3A-3D ). We did not detect any significant increase in cell death in wing buds treated with control beads soaked in PBS, indicating that bead implantation itself does not cause apoptosis in the manipulated limbs (Fig. 3F ). Our data suggest that some of the reductions seen in the cartilage elements of GDF11-treated wings could be due to increases in cell death and that GDF11, like BMPs 2, 4, and 7, can induce apoptosis in the early limb bud.
To investigate the effects of GDF11 on cell differentiation, we used micromass cultures of dissociated chick wing bud mesenchyme. When these cells are plated at high density, they spontaneously differentiate to form cartilage and muscle (Swalla and Solursh, 1986) and are a useful in vitro model for studying chondrogenesis. Micromass cultures were made from stage 23-24 wing buds and incubated for 3 days in the presence or absence of 250 ng/ml GDF11 or BMP-2. The cells were then assayed for changes in chondrogenesis by Alcian blue staining, which detects sulfated proteoglycans deposited in the cartilage matrix. As seen in Fig. 4A , control, untreated cultures formed many Alcian blue-positive cartilage nodules. The BMP-2-treated cultures showed enhanced chondrogenesis, forming sheet-like condensations of cartilage that were darkly stained with Alcian blue (Fig. 4B ). In contrast, cultures treated with GDF11 showed very little Alcian blue staining, indicating that cartilage formation had been inhibited (Fig. 4C ). These data suggest that GDF11 has a strong negative effect on the chondrogenic differentiation of limb mesenchyme in vitro.
To investigate the inhibitory effect of GDF11 on chondrogenesis in vivo, we performed histological analyses on sections from day 8 -9 skeletal preparations from contralateral control and treated wings (n ϭ 4). In normal avian cartilage (Figs. 5A-5D ), chondrocytes are arranged in three distinct zones with quiescent, rounded cells in the epiphyses (Fig. 5B) ; proliferative, flattened cells in the metaphyseal region (Fig. 5C) ; and hypertrophic chondrocytes in the diaphyseal region (Fig. 5D ). In the severely affected GDF11-treated humerus (Figs. 5E-5H ), the characteristic zones of chondrocytes are lost. Most cells within the cartilage element are round and the small number of flattened cells that can be found are not arranged in normal ordered rows (Fig.  5G) . Although the central core chondrocytes of the diaphysis have some denser staining matrix, they do not appear to have undergone hypertrophy or formed distinct lacunae (Fig. 5H ). Chondrogenesis appears delayed in the GDF11-treated wings, suggesting that the observed truncation of the skeletal elements may be due, in part, to an inhibition of chondrocyte cell differentiation.
Gdf11 Inhibits Muscle Development
Mature GDF11 shares 90% amino acid identity with GDF8, a potent negative regulator of skeletal muscle. The fact that these two proteins are so highly related and have very similar activities in vivo and in vitro (N. Wolfman, S. Thies, and L. Gamer unpublished observations) raises the possibility that GDF11 and GDF8 could signal through the same receptor. This led us to wonder if GDF11 could also have an inhibitory effect on limb muscle formation. To investigate this possibility, we implanted beads incubated in GDF11 protein into stage 20 -21 wing buds and looked for changes in the expression patterns of Pax3 and MyoD, markers of proliferating and differentiating myogenic cells, respectively (Olson, 1992; Williams and Ordahl, 1994) , 24 and 48 h after treatment. In the most severely truncated limbs, GDF11 caused a complete inhibition of Pax3 and MyoD expression (compare Figs. 6B to 6A and 6G to 6F) . In limbs with a milder phenotype, Pax3 and MyoD transcripts were still reduced in the area immediately around the bead (Figs. 6D and 6I ). Wing buds implanted with control beads did not show any alterations in the expression patterns of either Pax3 or MyoD (Figs. 6E and 6J ). These results suggest that GDF11 can inhibit myogenesis in the developing chick limb. This lack of developing muscle may also contribute to the truncated limb phenotype we observe.
To analyze the direct effect of GDF11 on myogenic cells, we treated micromass cultures of chick wing mesenchyme with GDF11 and compared these to cultures treated with BMP-2, which has been shown to inhibit muscle cell development in this system (Duprez et al., 1996) . After 3 days, the cells were assayed immunohistochemically for differentiated myoblasts using MF-20, a monoclonal antibody directed against sarcomeric myosin (Bader et al., 1982; Swalla and Solursh, 1986) . Control untreated cultures exhibited many darkly stained MF-20-positive myoblasts that clustered around the cartilage nodules (Fig. 4D) . In contrast, cultures treated with BMP-2 showed a significantly reduced number of muscle cells (Fig. 4E ) and in cultures treated with GDF11, there were even fewer MF-20-positive cells (Fig.  4F) . These data support our in vivo observations and suggest that GDF11 has a negative effect on the differentiation of mesenchymal cells in the limb into both the chondrogenic and the myogenic lineages.
The Progress Zone Is Unaffected by GDF11 Treatment
The progress zone is a region of proliferative, undifferentiated mesenchymal cells located directly beneath the AER. Cells move out of the progress zone to form cartilage elements and are thought to acquire proper positional information based on their residence time in the progress zone. Cells that leave first adopt proximal fates (humerus or femur) while those that exit later adopt more distal fates (digits). If the initial size of the progress zone is reduced, proximal limb structures are reduced or absent, but distal structures are present and normal (Summerbell et al., 1973) . As the phenotype observed when the progress zone is reduced is similar to what we see in GDF11 bead-implanted wings, we wanted to determine if treatment of the limb bud 
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with GDF11 was affecting the size of the progress zone. We analyzed the expression pattern of two markers of the progress zone, Msx-1 and Msx-2 (Robert et al., 1991) , by whole-mount in situ hybridization. Interestingly, we found that the expression patterns of both Msx-1 and Msx-2 were unchanged in the GDF11-treated limbs (Fig. 7A and data not shown), suggesting that the progress zone in the treated wings is not affected by GDF11 and that the observed shortening is due to another mechanism.
GDF11 Induces the Ectopic Expression of Hoxd Genes
In order to understand the molecular mechanism of GDF11 action in the limb, we analyzed the expression of markers of appendicular skeletal patterning. We chose to look at the effects of GDF11 treatment on the expression of Hoxa and Hoxd genes based on two observations: (1) Gdf11 appears to colocalize with several of these Hox genes in the distal mesenchyme of the early limb bud and (2) the shortened skeletal elements in the GDF11 limbs resemble those induced by retroviral misexpression of Hoxd-11 and Hoxd-13 (Goff and Tabin, 1997) . Beads incubated in GDF11 protein were implanted into stage 20 -22 limb buds and then collected for whole-mount in situ hybridization 24 h later. Implantation of control beads in stage 20 -22 wing buds had no effect on the endogenous expression pattern of any of the Hox genes we analyzed (data not shown). Figure  7B shows the normal expression pattern of Hoxd-13 in the distal, posterior mesenchyme of a stage 23-24 contralateral control wing bud. In Fig. 7C , strong ectopic expression of Hoxd-13 is seen around the GDF11 bead in the proximal and anterior region (n ϭ 5). Figure 7D reveals that GDF11 also induced a proximal and anterior expansion of the endogenous posterior-distal domain of Hoxd-11 in stage 23 wing bud (n ϭ 5). In contrast, GDF11 had no effect on the expression pattern of either Hoxa-11 or Hoxa-13 (data not shown). Our results suggest that the developmental abnormalities observed in the limb as a result of exogenous GDF11 may be mediated in part through a misregulation of Hoxd genes.
GDF11 Causes Upregulation of Its Antagonist, Follistatin
Members of the BMP family can modulate their own activity through feedback mechanisms involving the induction of specific extracellular antagonists. For example, it was recently shown that distal outgrowth of the chick limb is controlled, in part, by a regulatory loop between BMPs and gremlin (Merino et al., 1999b; Capdevila et al., 1999; Mercader et al., 1999) . Using Xenopus embryos, we have shown previously that follistatin is a specific inhibitor of GDF11 (Gamer et al., 1999) . Since GDF11 appears to have a strong effect on chick limb formation, we wanted to determine if a feedback mechanism existed to restrict GDF11 activity. In order to do this, we implanted beads soaked in GDF11 protein into stage 21 limb buds and assayed for changes in follistatin expression by whole-mount in situ hybridization. In the contralateral controls, endogenous follistatin is expressed proximally by muscle cells migrating into the limbs (Fig. 8A and Amthor et al., 1996) . In the GDF11-treated limbs, follistatin transcripts are ectopically induced in an area directly surrounding the bead (n ϭ 8) after 24 h (Figs. 8B and 8C ). This effect was specific for GDF11 as implantation of control beads did not alter follistatin expression. These data show that GDF11, like BMP-2 and BMP-4, can induce the expression of its own antagonist, and this may help to control its activity during limb development.
DISCUSSION
Gdf11 is a recently discovered member of the TGF-␤ family that has been shown to be a key regulator of patterning in the axial skeleton. Here we show that Gdf11 may also play an important role in the formation of the appendicular skeleton in the chick.
During avian limb development, Gdf11 is strongly expressed in the distal mesenchyme of the progress zone and appears to be excluded from chondrogenic areas that will eventually differentiate to form the limb skeleton. Exogenous application of GDF11 via bead implantation into the limb bud causes severe shortening of the wing, with both skeletal elements and muscle being affected. The truncation of the developing limbs due to GDF11 treatment appears to be due to a complex mechanism which involves an initial increase in apoptosis, followed by an inhibition of chondrogenesis and skeletal element growth (due to misregulation of Hox genes), as well as an inhibition of myogenesis (which may be due to cross reaction with GDF8 signaling pathways). Our results suggest that Gdf11 may function during the formation of the chick limb in two ways: first, to keep cells in the progress zone from differentiating and second, to help pattern the limb skeleton by regulating Hox gene expression.
When beads incubated in GDF11 protein were implanted into stage 20 -22 wing buds, the treated limbs were significantly shortened and the skeletal elements of the zeugopod and stylopod were truncated up to 50% of the length of the controls. This dramatic reduction in limb size was detected after only 24 h of GDF11 exposure, at stage 24 -25, when the mesenchymal cells are beginning to condense to form cartilage and the specific elements are still being specified. Since Gdf11 is so highly expressed in the distal mesenchyme and GDF11 treatment causes limb shortening very early on, we reasoned that GDF11 might be working by perturbing the size of the progress zone. Summerbell et al. (1973) showed that if the progress zone was made smaller, a properly patterned limb skeleton was formed but skeletal elements were reduced in size. While this phenotype is similar to what we saw in the GDF11-treated wings, the progress zone of the GDF11-treated limbs appeared normal, with no changes in cell proliferation or molecular markers. Therefore, the early reduction in limb size is probably due to another mechanism. We favor the idea that the early decrease in size of the limb is due to an increase in cell death caused by GDF11. This would reduce the initial number of mesenchymal cells that form the limb and could later contribute to truncations of the cartilage elements. It is unclear whether the cell death induced by GDF11 is happening directly or is an indirect consequence of cells not receiving the appropriate signals to differentiate. At this time, we prefer the latter explanation because, unlike BMP2 and 4, the expression pattern of Gdf11 does not correlate with the anterior necrotic zone, posterior necrotic zone, or interdigital mesenchyme, which are all areas of programmed cell death in the limb. In contrast, Gdf11 is highly expressed in an area that must stay proliferative and active for limb outgrowth.
Our in vitro and in vivo data imply that the shortening and widening of the limbs we observed is also due to a strong negative effect of GDF11 on chondrogenesis and chondrocyte cell differentiation. We found that in highdensity micromass cultures of limb mesenchymal cells, GDF11 blocked the formation of cartilage nodules. This is in contrast to other TGF-␤ family members, like TGF-␤1, TGF-␤2, and BMP-2, which enhance chondrogenesis in these cultures (Kulyk et al., 1989; Roark and Greer, 1994) . In addition, histologic analysis of GDF11-treated skeletal elements showed that GDF11 also affected chondrogenesis in vivo. Chondrocytes in the GDF11-treated wings appear immature, with few if any hypertrophic chondrocytes present. During normal skeletal development, terminal differentiation of hypertrophic chondrocytes results in a dramatic increase in long-bone size due to an increase in both cell size and amount of surrounding cartilage matrix. Our data suggest that the severe reduction in element size we see in the GDF11-treated wings may be due, in part, to the lack of hypertrophic cell differentiation. This negative effect on chondrogenesis correlates well with the observation that during the formation of the embryonic limb Gdf11 appears to be excluded from regions of the wing or leg undergoing cartilage differentiation.
The truncation of the limb can also be partially a result of GDF11 inhibition of muscle development. When the dorsal ectoderm is removed from early wing buds, myogenic cells stop proliferating and prematurely differentiate, exhausting the precursor pool and preventing further muscle growth (Amthor et al., 1998) . This eventually leads to limb truncations in which both the stylopod and the zeugopod are shortened (Amthor et al., 1998) . This phenotype is very similar to what we see in the GDF11-treated wings, but the question arises as to whether this is a specific effect of GDF11. The highly related GDF8 and GDF11 proteins could share a common receptor, or each of these molecules could bind and activate the other ligand's receptor . Adult mice carrying a targeted disruption of Gdf8 exhibit a dramatic increase in skeletal muscle mass (McPherron et al., 1997) . Based on this phenotype, one would predict seeing a decrease in the amount of muscle when GDF8 is overexpressed. Interestingly, in the GDF11-treated limbs, muscle development is inhibited and Pax3 and MyoD are both downregulated. Our preliminary results suggest that GDF8 and GDF11 induce equivalent phenotypes in the chick limb (L. Gamer, K. Cox, and V. Rosen, unpublished observations); therefore it will be very difficult to distinguish the individual effects of each of these molecules until the GDF8 and GDF11 signaling pathways have been identified.
The expression of Gdf11 during limb development in the distal mesenchyme overlaps with the expression domains of a number of factors that are thought to play major roles in patterning the limb, including some of the Hox genes. Hox genes have been shown to have an early role in regulating the growth of undifferentiated limb mesenchyme and a later role in regulating the maturation of the forming skeletal elements (Morgan and Tabin, 1994) . Misexpression of Hoxd-11 and Hoxd-13 by retroviral vectors in the early chick limb leads to a decrease in the length of the limb bones (Goff and Tabin, 1997) , a phenotype very similar to what we see with GDF11 treatment. When we analyzed the GDF11-treated limbs, we found that both Hoxd-11 and Hoxd-13 were ectopically induced around the bead, and their normal distal domain of expression was expanded proximally. The alterations in the shape of the skeletal elements we are observing may be due, in part, to the misexpression of Hoxd-11 and Hoxd-13 in regions where they are not normally found, thus causing the limb to be shorter and wider. Our data suggest that GDF11 may act upstream of Hox genes in the chick limb to regulate their expression during the patterning of the appendicular skeleton. These data fit well with what is observed in the Gdf11 knockout mice, in which Hox genes are misregulated in the axial skeleton leading to actual homeotic transformation of vertebral segments .
Our results demonstrate that GDF11 can affect chick limb development. Given the conservation of signaling pathways between the mouse and the chick during limb patterning and formation, how do we then explain the observations by McPherron et al. (1999) that the limb skeleton appears unaffected in the Gdf11 null mice? We suggest several possibilities. There may be compensation by other members of the TGF-␤ superfamily that are expressed in the limb as seen in the BMP-6 and BMP-7 knockout mice (Solloway et al., 1998; Lou et al., 1995; Dudley et al., 1996) . Another possibility is that the phenotype we observe is a result of exogenous GDF11 activating additional TGF-␤/BMP signaling pathways involved in limb formation. This seems unlikely for two reasons. First, increased signaling through the BMP pathway via overexpression of constitutively active BMPR-1A and BMPR-1B in early limb buds leads to dramatic expansion of chondrogenesis (Zou et al., 1997) , an effect opposite to what we see with GDF11 treatment. Alternatively, increased signaling through an activin pathway either has no effect on skeletal development (Merino et al., 1999a) or results in increased chondrogenesis (Jiang et al., 1993) , again, the opposite of our results. Therefore we believe the inhibition of chondrogenesis and myogenesis we observe with GDF11 treatment is not an artifact of high localized expression of the protein but represents a previously undiscovered role for GDF11 in the limb.
A surprising finding of our studies is that exogenous application of GDF11 in the limb bud induces the ectopic expression of follistatin, an antagonist of GDF11. This suggests that the activity of GDF11 is limited by negative feedback. Strict control of the action of GDF11 appears to be necessary for proper limb formation as we have shown that overexposure of mesenchymal cells to GDF11 causes limb truncations and inhibits both chondrogenesis and myogenesis. The upregulation of follistatin is most likely not a major contributing factor to the phenotype we observe because implantation of follistatin beads at the same stage has no effect on limb development (Merino et al., 1999a) . However, we cannot rule out the possibility that follistatin upregulation could block signaling by BMPs or activin. Feedback regulation of GDF11 in limb appears similar to what has been recently demonstrated for other BMP family members and their antagonists. When beads incubated in BMP4 are applied to developing somites, the expression of noggin is upregulated, maintaining a balance between proliferation and differentiation of embryonic muscle (Amthor et al., 1999) . In addition, induction of noggin has been documented in both cultured rat osteoblasts and mouse forelimb organ cultures treated with BMPs 2 and 7 (Gazzerro et al.,1998; Nifuji and Noda, 1999) . These data imply that the coordinated regulation of BMPs/GDFs and their inhibitors may be essential for proper skeletal and muscle development during embryogenesis. These results also suggest the possibility that in specific tissues, inhibitors such as noggin and follistatin could act as inducible binding proteins for BMPs, preventing overexposure of cells to these potent growth factors.
Limb mesenchymal progenitor cells can give rise to chondrocytes, osteoblasts, adipocytes, myoblasts, or connective tissue. In micromass cultures, GDF11 is a potent inhibitor of chondrogenesis and myogenesis. One important question that arises from our studies is the identity of the GDF11-treated cells-do they remain as mesenchymal stem cells or are they pushed into another cell fate? Recent evidence suggests that follistatin is able to inhibit tendon formation in the developing chick foot (D'Souza and Patel, 1999) . Since follistatin is an antagonist of GDF11-could GDF11 have the opposite effect and induce the formation of tendon? Our preliminary data from bead implantation experiments in the chick foot indicate that GDF11 induces a dense connective tissue in an area around the bead that is positive for the early tendon marker EphA4 (L. Gamer, K. Cox, and V. Rosen, unpublished observations). Future experiments will address the role of GDF11 in tendon formation and patterning in the developing chick autopod and may further elucidate the function of GDF11 in the embryonic limb skeleton.
